Latest Visual acuity Stories
Among adolescents, visual acuity tests appear to reliably detect vision problems caused by nearsightedness but not farsightedness or astigmatism.
SARATOGA, Calif., July 6 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the U.S. Food and Drug Administration (FDA) has approved the company's Implantable Miniature Telescope (by Dr.
MOUNTAIN VIEW, Calif., June 17 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) announced the recent publication of a clinical study comparing results obtained in the treatment of diabetic macular edema (DME) using an IRIDEX laser and MicroPulse(TM) treatment protocol to those obtained using the recognized standard of care Early Treatment of Diabetic Retinopathy Study (ETDRS) laser protocol.
An inexpensive, but unlicensed drug to help prevent severe sight loss in older people has been shown to be safe and effective.
A novel scleral lens developed in Boston proves clinically beneficial in patients who have failed conventional therapies.
NORTH CHICAGO, Ill., Nov.
This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of two Academy-sponsored online eye health forums.
A report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmologists suspect an atypical variant of Alzheimer's disease.
Highlights of October's Ophthalmology, the journal of the American Academy of Ophthalmology, include good news on preserving vision in people with type 1 diabetes, a warning from the Cardiovascular Health Study for macular degeneration patients, and a report on how vision impacts well-being across the lifespan.
TARRYTOWN, N.Y., Sept. 14 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc.